Canadian Securities ExchangeThe Daily Bell

BioMark Diagnostics Inc.

BioMark Diagnostics Inc. (CSE:BUX) is listed on the Canadian Securities Exchange in the Life Sciences sector, since November 3, 2014. The CSE has covered it in 2 stories since 2025.

CSE:BUXCompany profile on thecse.com

Jun 4, 2025CSE Issuer Stories

Early Cancer Detection Using Biomarkers Could Save Lives and Healthcare System Resources

Early detection is critical to improving survival rates and treatment outcomes for cancer patients, but traditional approaches such as mammograms, low-dose CT scans, and biopsies, while effective, come with challenges. High costs, accessibility, invasiveness, and the potential for false positives are some of the factors that can lead to delays in diagnosis or unnecessary treatments.…

BioMark Diagnostics Inc. (CSE:BUX)

May 28, 2025Magazine

Canadian Securities Exchange Magazine: The Technology Issue – Now Live!

Welcome to the latest issue of Canadian Securities Exchange Magazine, your source for in-depth stories of entrepreneurs from a wealth of different industries. Businesses are facing an operating landscape marked by mounting political tensions, rapidly shifting climate and trading realities around the world, and continuously evolving technology – particularly artificial intelligence (AI) – driving an…

BioMark Diagnostics Inc. (CSE:BUX)